# V1 Empirics Check — openai/gpt-5.1-codex-mini (Variant A)

**Model:** openai/gpt-5.1-codex-mini
**Variant:** A
**Date:** 2026-03-22T14:39:36.135944

---

**Idea Fidelity**

The paper largely tracks the original manifest in spirit—using the staggered timing of GP ‘closures’ to assess impacts on A&E visits via NHS administrative data and DiD/event-study approaches. However, there are a few deviations that weaken the link to the manifest’s intended identification strategy. First, the treatment is defined at the trust level as “first closed practice within 15 km,” whereas the manifest planned for a more granular local-area analysis (e.g., CCG/ICB or travel-shed-based). Second, while the manifest emphasized the causal effect of genuine access loss (with anticipated mechanisms via list growth and workforce dilution at surviving practices), the paper pivots to a null result driven by administrative reclassifications in 2023. The identification strategy as executed therefore addresses the relationship between administrative inactivity and trust-level attendances, but it does not convincingly isolate genuine reductions in local primary care access and hence falls somewhat short of the original research question. A clearer connection to the manifest—distinguishing real closures from administrative churn in the treatment definition and explicitly modeling the hypothesized mechanisms—would improve fidelity.

---

**Summary**

This paper investigates whether GP practice closures in England, identified via NHS ODS records, cause increases in Type‑1 A&E attendances at nearby trusts, exploiting staggered treatment timing in a trust-level DiD/event-study framework. Across TWFE, Callaway–Sant’Anna, and robustness checks (e.g., distance bandwidths, COVID exclusion), the estimates remain statistically indistinguishable from zero, leading the author to conclude that the widespread administrative deactivations recorded in 2023 do not translate into aggregate A&E spillovers. The null is interpreted as evidence that most recorded “closures” are administrative rather than substantive shocks to access.

---

**Essential Points**

1. **Treatment Definition and Interpretation of Closure Events:** The paper uses ODS “inactive” status as a proxy for GP closures but acknowledges that many deactivations (especially the 2023 spike) are administrative reorganizations. Without further validation, the key identifying variation may not correspond to actual access shocks. The estimated zero effect could simply reflect the fact that the “treatment” never disrupts patient access. The authors need to bolster the treatment definition—e.g., by differentiating likely real closures (practice site disappears, patient list shrinks, workforce drops) from administrative code changes—and show that the variation they exploit corresponds to meaningful changes in local primary care provision. This is essential for the causal interpretation.

2. **Spatial and Temporal Mapping to Trusts:** Mapping practice closures to the nearest A&E trust via a fixed 15 km radius may mix causally relevant closures with distant administrative noise, especially since some trusts have large catchment areas and multiple nearby practices. The paper currently lacks evidence that closures within this radius materially affect the specific trust’s patient base or that the chosen radius aligns with patient behavior. The credibility of the DiD hinges on whether treated trusts actually “lose” patients who would have used their A&E. Provide justification (e.g., patient registration flows, share of practice population attributable to each trust) or alternative mappings (e.g., travel-time weighted linkages, practice-to-trust patient flows) and show results are robust to those.

3. **Parallel Trends and Control Group Validity:** Although the event study shows flat pre-trends, the treated and never-treated trusts differ markedly in size, location, and pre-trends in utilization (Table 1 shows treated trusts have a mean Type 1 count ten times higher than never-treated). The paper rests on the assumption that never-treated trusts are an appropriate counterfactual, yet the main DiD specification lacks time-varying controls or trust-specific trends to absorb differential shocks correlated with unobserved heterogeneity (e.g., urbanization, broader access changes, post-pandemic rebound). Provide additional evidence (e.g., balancing tests, falsification on pre-trends using matched controls, inclusion of trust-specific linear trends) to confirm that comparison is valid; otherwise the null may reflect offsetting trends rather than the absence of an effect.

If addressing these points is infeasible (e.g., because the treatment measure cannot be refined), the paper should be rejected, as the causal claims would not hold.

---

**Suggestions**

1. **Refine and Validate the Treatment Variable**

   - **Distinguish real from administrative closures**: Use supplementary data (e.g., practice workforce counts, patient list sizes, site addresses) to identify closures that involve site shutdowns or list drops versus mere code retirements/reorganizations. For instance, compare practice-level workforce or registered patient trends before/after deactivation; administrative mergers should show smooth list totals, whereas bona fide closures should show abrupt declines. Restrict the main analysis to events that demonstrate tangible access loss (e.g., >20% patient list reduction, no immediate successor practice at the same postcode) and re-estimate the DiD. Even if this reduces sample size, it would better align with the research question.

   - **Leverage NHS England or CQC data**: Some datasets (e.g., CQC inspection reports, “Practice closures or mergers” public notices) explicitly note when a physical site closes. Matching ODS events to those records can help validate the classification, enabling a more credible subset of genuine closures.

2. **Improve geographic linkage and treatment intensity measures**

   - **Incorporate patient flow information**: If available, use data on which hospital trust is most frequently used by patients of each practice (possible through Hospital Episode Statistics or aggregated referral patterns) to weight the relevance of a closure to each trust rather than relying solely on proximity.

   - **Consider catchment-area or travel-time mapping**: A fixed radius (15 km) may misrepresent patient behavior, especially in rural areas where people travel farther. Consider defining treatment as closures within the trust’s catchment area, or use travel-time-based boundaries (e.g., within 20 minutes by car) to better approximate the relevant patient pool. Alternatively, run sensitivity analyses with varying radii (which you partially do) but report how treated trust lists change and whether results are consistent across rural/urban subsets.

   - **Explore treatment intensity**: Instead of a binary post indicator once any nearby closure occurs, use the number of closures weighted by patient list sizes or share of trust catchment affected. That would allow testing whether larger shocks shift results—and could reveal nonlinearities masked by the binary indicator.

3. **Strengthen identification by accounting for time-varying confounders**

   - **Include trust-specific trends or covariates**: Large trusts might face different trends, e.g., urban trusts recovering faster post-COVID or subject to different system pressures. Incorporating trust-specific linear (or flexible) trends in the TWFE regressions can control for such differential dynamics. If trends differ substantially, even pre-trend coefficients near zero might not reassure.

   - **Perform synthetic control or matching exercises**: To validate that never-treated trusts represent a good counterfactual, compare treated trusts to matched controls based on pre-treatment covariates (e.g., baseline attendances, urbanicity, deprivation index). Estimate the same event study on matched samples to see if outcomes differ.

   - **Falsification tests**: Go beyond total attendances by testing outcomes that should not be affected, such as planned elective admissions or outpatient visits, to verify no spurious treatment effects. This would increase confidence that the null is not due to residual confounding.

4. **Explore heterogeneity and mechanism proxies**

   - **Analyze deprivation or distance heterogeneity**: As outlined in the manifest, heterogeneity across IMD scores or distance to next GP should be illuminating. Even if the aggregate effect is zero, there may be subgroups (e.g., the most deprived areas) where closures do pressurize A&E. Explore heterogeneity by interacting treatment with area deprivation, rural/urban status, or pre-existing GP density.

   - **Test mechanism proxies**: Since direct data on patient re-registration are unavailable, use available proxies such as changes in staff-to-list ratios at surviving practices, phone-booking wait times (if accessible), or list growth at nearby practices after closures. Showing that closures caused measurable changes in GP workloads but still no A&E spike would substantiate the argument about NHS buffering.

5. **Address the 2023 spike directly in the analysis**

   - If most closures occurred in 2023 due to administrative reassignments, the main sample may not be informative about genuine shocks. Consider re-running the main analysis excluding 2023 events entirely or weighting earlier events more heavily. Additionally, present descriptive statistics on the 2023 cohort versus earlier ones (e.g., comparison of workforce changes, patient counts) to substantiate the claim that they are administrative. If the null persists even when focusing on pre-2023 “real” closures, the conclusion is much stronger.

6. **Clarify interpretational limits and policy implications**

   - A precisely zero trust-level effect does not imply there are no localized access problems. Emphasize this caveat explicitly, perhaps by linking to existing qualitative evidence or discussing how aggregated trust-level data may mask micro-level disruptions (e.g., for vulnerable groups). Policymakers would benefit from guidance on whether additional monitoring (e.g., patient-level trajectories) is warranted.

7. **Enhance robustness reporting**

   - Provide more details on the Callaway–Sant’Anna implementation: how cohorts are defined, whether cohort weights vary, and whether the dynamic ATT plots mirror the TWFE event study. Present the cohort-specific estimates to show whether early or late closures behave differently.

   - Include placebo leads (e.g., fake closure dates) to further demonstrate that the event-study coefficients are not driven by model specification.

By tightening the treatment definition, bolstering the spatial linkage, and deepening robustness checks, the paper can more convincingly answer whether real GP access shocks spill over into A&E demand, rather than concluding from administrative noise.
